Chris B. Russell

Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

Kim Papp, Craig L. Leonardi, Alan Menter et al. · New England Journal of Medicine · 2012 · 929 citations

Medicine, Dermatology, Pharmacotherapy +17

A prospective phase III, randomized, double‐blind, placebo‐controlled study of brodalumab in patients with moderate‐to‐severe plaque psoriasis

Kim Papp, Kristian Reich, C. Paul et al. · British Journal of Dermatology · 2016 · 459 citations

Medicine, Dermatology, Pharmacotherapy +13

Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A

John Pasi, Savita Rangarajan, Nina Mitchell et al. · New England Journal of Medicine · 2020 · 458 citations · Full text

Medicine, Hematology, Molecular Medicine +13

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease

Stephan R. Targan, Brian G. Feagan, Séverine Vermeire et al. · The American Journal of Gastroenterology · 2016 · 372 citations

Veterinary Medicine, Immunology, Pharmacotherapy +16

Chromosomal transformation of Escherichia coli recD strains with linearized plasmids

Chris B. Russell, David S. Thaler, Frederick W. Dahlquist · Journal of Bacteriology · 1989 · 168 citations · Full text

Life Sciences, Genetics, Microbiology +17